|
MaxipimeDrug - Maxipime The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Cefepime Hydrochloride (arginine Formulation)
Strength -
EQ 2GM BASE/VIAL
Applicant -
BRISTOL MYERS SQUIBB
New Drug Application (NDA) Number -
050679
Product Number -
003
Therapeutic Equivalence (TE) Code -
Approval Date -
Jan 18, 1996
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Bristol Myers Squibb Co Pharmaceutical Research Institute
Maxipime
Omnicef 300mg Capsule; Oral
Omnicef 125mg/5ml For Suspension; Oral Omnicef 250mg/5ml For Suspension; Oral Spectracef 200mg Tablet; Oral Maxipime Eq 1gm Base/vial Injectable; Injection Maxipime Eq 2gm Base/vial Injectable; Injection Kefzol Eq 20gm Base/vial Injectable; Injection Kefzol Eq 250mg Base/vial Injectable; Injection Kefzol Eq 500mg Base/vial Injectable; Injection Kefzol Eq 500mg Base/vial Injectable; Injection NewDrugInformation |